• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体系统补体激活与肾移植受者的急性排斥反应有关。

Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.

机构信息

Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Transplantation. 2011 Jul 27;92(2):163-9. doi: 10.1097/TP.0b013e318222c9a0.

DOI:10.1097/TP.0b013e318222c9a0
PMID:21677599
Abstract

BACKGROUND

Acute rejection after renal transplantation has been shown to be negatively associated with long-term graft survival. Identifying donor factors that are associated with acute rejection in the recipient could help to a better understanding of the relevant underlying processes that lead to graft injury. Complement activation has been shown to be an important mediator of renal transplant related injury. In this study, we analyzed the effect of systemic complement activation in deceased donors before transplantation of their kidneys on posttransplant outcome in the recipient.

METHODS

Plasma from 232 deceased brain-dead and deceased cardiac-dead donors were analyzed for the complement activation markers C5b-9, C4d, Bb, and complement component mannan binding lectin by ELISA. The association of these parameters with posttransplant outcome in recipients was analyzed in a multivariate regression model.

RESULTS

It was found that C5b-9 level in donor plasma is associated with biopsy-proven acute rejection in the recipient during the first year after renal transplantation (P = 0.035). Both in deceased brain-dead and deceased cardiac-dead donors increased complement activation was found.

CONCLUSIONS

In conclusion, we found C5b-9 in the donor to be associated with acute rejection of renal transplants in the recipient. Whether targeting complement activation in the donor may ameliorate acute rejection in the recipient needs to be studied.

摘要

背景

肾移植后的急性排斥反应已被证明与长期移植物存活率呈负相关。确定与受者急性排斥反应相关的供者因素有助于更好地了解导致移植物损伤的相关潜在过程。补体激活已被证明是肾移植相关损伤的重要介质。在这项研究中,我们分析了 232 例脑死亡和心死亡供者在移植前其肾脏的系统性补体激活标志物 C5b-9、C4d、Bb 和补体成分甘露聚糖结合凝集素的血浆水平,通过 ELISA 进行分析。在多变量回归模型中分析了这些参数与受者移植后结局的关系。

结果

发现供者血浆中的 C5b-9 水平与肾移植后 1 年内受者活检证实的急性排斥反应有关(P=0.035)。在脑死亡和心死亡供者中均发现补体激活增加。

结论

总之,我们发现供者的 C5b-9 与受者的肾移植急性排斥反应有关。是否可以通过靶向供者的补体激活来减轻受者的急性排斥反应,仍需要进一步研究。

相似文献

1
Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient.供体系统补体激活与肾移植受者的急性排斥反应有关。
Transplantation. 2011 Jul 27;92(2):163-9. doi: 10.1097/TP.0b013e318222c9a0.
2
Lectin complement pathway gene profile of the donor and recipient does not influence graft outcome after kidney transplantation.供者和受者的凝集素补体途径基因谱不影响肾移植后的移植物结局。
Mol Immunol. 2012 Feb;50(1-2):1-8. doi: 10.1016/j.molimm.2011.11.009. Epub 2011 Dec 15.
3
Complement activation in early protocol kidney graft biopsies after living-donor transplantation.活体供肾移植后早期方案肾移植活检中的补体激活
Transplantation. 2003 Apr 27;75(8):1204-13. doi: 10.1097/01.TP.0000062835.30165.2C.
4
Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?晚期急性肾移植排斥反应中肾小管周围毛细血管C4d染色——有相关性吗?
Clin Transplant. 2008 Jan-Feb;22(1):61-7. doi: 10.1111/j.1399-0012.2007.00745.x.
5
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.临床肾移植再灌注后末端补体复合物的急性短暂释放。
Transplantation. 2013 Mar 27;95(6):816-20. doi: 10.1097/TP.0b013e31827e31c9.
6
Pathological study on the relationship between C4d, CD59 and C5b-9 in acute renal allograft rejection.急性肾移植排斥反应中C4d、CD59与C5b-9关系的病理学研究
Clin Transplant. 2004;18 Suppl 11:18-23. doi: 10.1111/j.1399-0012.2004.00242.
7
Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.伴有肾小管周围毛细血管C4d沉积的同种异体肾移植中凝集素途径激活的免疫组化证据。
Nephrol Dial Transplant. 2006 Sep;21(9):2589-95. doi: 10.1093/ndt/gfl210. Epub 2006 Apr 27.
8
Outcome of a solitary kidney transplant into adult recipients from pediatric donors after controlled circulatory death.儿童供体在循环死亡后对成年受者进行单肾移植的结果
Exp Clin Transplant. 2011 Jun;9(3):165-9.
9
The UNOS renal transplant registry.美国器官共享联合网络肾脏移植登记处。
Clin Transpl. 2001:1-18.
10
The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome.供体和受体年龄的组合在决定宿主免疫反应性和肾移植结果方面至关重要。
Ann Surg. 2010 Oct;252(4):662-74. doi: 10.1097/SLA.0b013e3181f65c7d.

引用本文的文献

1
Improving outcomes in kidney transplantation through advances in donor organ perfusion.通过供体器官灌注技术的进步改善肾移植的效果。
Nat Rev Nephrol. 2025 Sep 9. doi: 10.1038/s41581-025-00993-8.
2
Comprehensive profiling of cell type-specific expression and distribution of complement genes in mouse and human kidneys: insights into normal physiology and response to kidney transplantations.小鼠和人类肾脏中补体基因的细胞类型特异性表达及分布的综合分析:对正常生理学及肾移植反应的见解
Ren Fail. 2025 Dec;47(1):2471568. doi: 10.1080/0886022X.2025.2471568. Epub 2025 Feb 27.
3
Exploring Potential Complement Modulation Strategies for Ischemia-Reperfusion Injury in Kidney Transplantation.
探索肾移植中缺血再灌注损伤的潜在补体调节策略。
Antioxidants (Basel). 2025 Jan 8;14(1):66. doi: 10.3390/antiox14010066.
4
Activation of the Innate Immune System in Brain-Dead Donors Can Be Reduced by Luminal Intestinal Preservation During Organ Procurement Surgery - A Porcine Model.在器官获取手术中通过肠腔保存来减少脑死亡供者固有免疫系统的激活 - 一种猪模型。
Transpl Int. 2024 Oct 31;37:13569. doi: 10.3389/ti.2024.13569. eCollection 2024.
5
HS-Enriched Flush out Does Not Increase Donor Organ Quality in a Porcine Kidney Perfusion Model.富含高渗盐水的冲洗在猪肾灌注模型中不会提高供体器官质量。
Antioxidants (Basel). 2023 Mar 19;12(3):749. doi: 10.3390/antiox12030749.
6
The Complement System in Kidney Transplantation.补体系统在肾移植中的作用。
Cells. 2023 Mar 2;12(5):791. doi: 10.3390/cells12050791.
7
Complement Inhibition in Kidney Transplantation: Where Are We Now?补体抑制在肾移植中的应用:现状如何?
BioDrugs. 2023 Jan;37(1):5-19. doi: 10.1007/s40259-022-00567-1. Epub 2022 Dec 13.
8
Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for delivery.补体靶向治疗移植物缺血再灌注损伤及递送的可能性。
Front Immunol. 2022 Oct 19;13:1000172. doi: 10.3389/fimmu.2022.1000172. eCollection 2022.
9
The Effect of Hypothermic Machine Perfusion to Ameliorate Ischemia-Reperfusion Injury in Donor Organs.低温机器灌注对改善供体器官缺血再灌注损伤的影响。
Front Immunol. 2022 Apr 29;13:848352. doi: 10.3389/fimmu.2022.848352. eCollection 2022.
10
Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.活性抗体介导的肾脏排斥反应中端补体表达微弱。
Front Immunol. 2022 Apr 13;13:845301. doi: 10.3389/fimmu.2022.845301. eCollection 2022.